GT Biopharma GTBP
NASDAQ GTBP
$5.41 -1.90 (-25.99%)
At close: Oct 21, 2026 · 4:00 PM EDT

GT Biopharma (GTBP) Revenue (2010 - 2015)

Updated

GT Biopharma (GTBP) reported Revenue of $27,000 for FY2015, down 55.7% from $61,000 in FY2014.

Analysis

GT Biopharma (GTBP) Revenue (2010 - 2015) Analysis & Trends

Dating back to FY2010, GT Biopharma's Revenue record includes 5 years.

  • Revenue has a five-year compound annual growth rate of 19.7% (FY2010 to FY2015).
  • The FY2015 figure ranks as the lowest annual Revenue since FY2011.
  • According to Business Quant data, Revenue came in at $61,000 in FY2014, $342,000 in FY2012 and $26,000 in FY2011 (+136.4%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 25.31 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 16.99 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 15.38 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 7.80 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 15.03 Bn
10 GT Biopharma 6.53 Mn -16.96 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 20,000.00
Mar 31, 2015 7,000.00
Mar 31, 2013 88,000.00
Dec 31, 2012 219,000.00
Sep 30, 2012 120,000.00
Jun 30, 2012 1,000.00
Mar 31, 2012 1,000.00
Dec 31, 2011 3,000.00
Sep 30, 2011 2,000.00
Jun 30, 2011 1,000.00
Mar 31, 2011 20,000.00
Dec 31, 2010 11,000.00
API Access

GT Biopharma Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=GTBP&period=max&api_key=YOUR_API_KEY